Latest Amphetamines Stories
The Corporate Whistleblower Center is urging pharmaceutical company representatives, managers, or physicians to call them at 866-714-6466, if they have well documented proof a drug company is
Pharmaceutical Company Agrees to Pay U.S.
PHILADELPHIA, September 24, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), today announced that it has reached a final agreement with the U.S.
TORONTO, Sept. 24, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), today announced the appointment of Dr. Floyd R.
PHILADELPHIA, September 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food and
LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies
DUBLIN, June 30, 2014 /PRNewswire/ -- Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) announces that its Canadian subsidiary(1) has received assessments from
LEXINGTON, Massachusetts, June 25, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Judge Stanley R.
MIDDLESEX, N.J., June 4, 2014 /PRNewswire/ -- CorePharma, LLC ("CorePharma"), a developer, manufacturer, and marketer of targeted generic prescription pharmaceuticals, announced today that it
Genetic variants associated with enjoying the effects of d-amphetamine—the active ingredient in Adderall—are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder (ADHD).
- A poem in which the author retracts something said in an earlier poem.